Dallas 3/24/2011 8:37:13 AM
News / Finance

GFRE, LZEN, LCI, COWN, ORB: Increased Activity Detected in These Names

Increased Activity Detected in These Names: GFRE, LZEN, LCI, COWN, ORB

Lizhan Environmental (NASDAQ:LZEN) has been relatively unchanged to settle at $2.94. For the past 52 weeks the stock has been trading between $3.05 and $4.25 with an average volume of 20,000 shares.

Lizhan Environmental Corporation (Lizhan Environmental), formerly Illigate Environment Resources Technology Company Limited, is a holding company. The Company conducts all of its operations through Lizhan Textile (Zhejiang) Co., Ltd. (Lizhan Textile). The Company, through Lizhan Textile, is a manufacturer, distributer and marketer of synthetic leather and other fabrics from recycled leather waste. Its production facilities are located in Tongxiang, Zhejiang Province.

Gulf Resources (NASDAQ:GFRE) has lost 3.6% or 25 cents a share to settle at $6.62 with a volume of 489,000 shares. For the past 52 weeks the stock has been trading between $6.28 and $13.10 with an average volume of 280,000 shares. Company has a current market cap of $314 million.

Gulf Resources, Inc. (Gulf Resources) manufactures and trades bromine and crude salt, and manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals. As of December 31, 2009, its products have been sold only within the People's Republic of China. Gulf Resources business operations are conducted in two segments: bromine and crude salt, and chemical products.

Lannett Company (AMEX:LCI) has lost 0.2% or one cents a share to settle at $5.47 with a volume of 110,895 shares. For the past 52 weeks the stock has been trading between $3.66 and $7.00 with an average volume of 216,000 shares. Company has a market capitalization of $156 million with a price to earnings ratio of 20.52 for the trailing 12 months.

Lannett Company, Inc. (Lannett) develops, manufactures, markets and distributes generic versions of branded pharmaceutical products. All of its products manufactured and/or sold are prescription products. Levo, Digoxin, Butalbital, Cocaine and Morphine Sulfate are the Company's core products, accounting for approximately 75% of its net sales during the fiscal year ended June 30, 2010 (fiscal 2010). Its products containing Levo are produced and marketed with 12 varying potencies.

Cowen Group Inc. (NASDAQ:COWN) has gained 2.62% or $.10 a share to settle at $3.92 with a volume of 327,650. For the past 52 weeks the stock has been trading between $2.99 and $6.02 with an average volume of 222,000 and a current market capitalization of $309 million.

Cowen Group, Inc. is an investment bank that provides research, sales and trading, and investment banking services to companies and institutional investor clients in the healthcare, technology, telecommunications, alternative energy, consumer and aerospace & defense sectors. As of December 31, 2008, its research and sales and trading services were provided to over 1,000 domestic and international clients seeking to trade equity, convertible and other equity-linked securities, in its target sectors.

Orbital Sciences Corp. (NYSE:ORB) has been relatively unchanged, settled at $18.37 a share. For the past 52 weeks the stock has been trading between $12.66 and $19.63 with an average volume of 270,000 shares. Company has a market capitalization of $1 billion and trades with a trailing 12 month P/E ratio of 21.68.

Orbital Sciences Corporation, incorporated in 1987, is engaged in the development and manufacture of small- and medium-class rockets and space systems for commercial, military and civil government customers, including the United States Department of Defense (DoD), the National Aeronautics and Space Administration (NASA) and other United States Government agencies. Its products and services include launch vehicles, satellites and space systems, and advanced space programs.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCpicks.com has not been compensated for any current or recent stocks listed in this stock news report